Categories
Uncategorized

Controversial drug approval stokes concern about lack of a permanent FDA chief

Technology Manias – EᐯEᖇYTᕼIᑎG YOᑌ ᑎEEᗪ IᑎᗪEEᗪ

The Food and Drug Administration’s approval of a controversial new Alzheimer’s drug this week has hardened opposition to acting commissioner Janet Woodcock, who remains President Joe Biden’s apparent favorite to be the agency’s permanent leader. The administration’s search for a permanent FDA head has dragged on for months during an unprecedented public health crisis. Woodcock, a veteran regulator, has presided over major decisions on the pandemic response, tobacco and new medicines — including the $56,000-a-year Biogen Alzheimer’s drug approved Monday despite thin evidence that it works. Woodcock appeared to distance…

The post Controversial drug approval stokes concern about lack of a permanent FDA chief appeared first on Technology Manias.

Leave a Reply

Your email address will not be published. Required fields are marked *